A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer

United States, Florida

Miami Cancer Institute
**RECRUITING NOW**

Miami, Florida, United States, 33176

Contact: Govindarajan Narayanan, MD         

University of South Florida/Tampa
**RECRUITING NOW**

Tampa, Florida, United States, 33606

Contact: Thanh Tran         

Principal Investigator: Vic Velanovich, MD         

United States, Illinois

Northwest Community Healthcare
**RECRUITING NOW**

Arlington Heights, Illinois, United States, 60005

Contact: Henry Mantakul         

Principal Investigator: Malcolm Bilimoria, MD         

United States, Kentucky

Norton Healthcare
**RECRUITING NOW**

Louisville, Kentucky, United States, 40202

Contact: Mary Healey         

United States, Pennsylvania

St. Luke’s Cancer Center
**RECRUITING NOW**

Easton, Pennsylvania, United States, 18045

Contact: Janine Schippang         

Principal Investigator: Darius Desai, MD         

United States, Texas

University of Texas-Southwestern
**RECRUITING NOW**

Dallas, Texas, United States, 75231

Contact: Misbah Shabbir         

Principal Investigator: Patricio Polanco, MD         

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 26, 2022Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments